We are live on ! Find out more
ITP

Iron Triangle Partners Portfolio holdings

AUM $875M
1-Year Est. Return 49.85%
This Fund
S&P 500
This Quarter Est. Return
-5.67%
1 Year Est. Return
+49.85%
3 Year Est. Return
+151.9%
5 Year Est. Return
+239.84%
10 Year Est. Return
–
AUM
$841M
AUM Growth
+$123M
Cap. Flow
+$161M
Cap. Flow %
19.1%
Top 10 Hldgs %
53.06%
Holding
33
New
8
Increased
13
Reduced
7
Closed
5

Top Buys

Rank Stock Value
1
ICLR icon
Icon
ICLR
+$39.5M
2
ILMN icon
Illumina
ILMN
+$38.2M
3
DXCM icon
DexCom
DXCM
+$30.6M
4
HQY icon
HealthEquity
HQY
+$26.3M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$25.9M

Top Sells

Rank Stock Value
1
DVA icon
DaVita
DVA
+$51.2M
2
NVST icon
Envista
NVST
+$35.1M
3
CRL icon
Charles River Laboratories
CRL
+$26.4M
4
AHCO icon
AdaptHealth
AHCO
+$17.1M
5
TMO icon
Thermo Fisher Scientific
TMO
+$16M

Sector Composition

Rank Sector Weight
1 Healthcare 98.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MASS icon
26
908 Devices
MASS
$293M
$13.6M 1.61%
+713,105
New +$12.3M
OHPAU
27
DELISTED
Orion Acquisition Corp. Unit
OHPAU
$9.81M 1.17%
999,513
-6,716
-0.7% -$66.1K
STXS icon
28
Stereotaxis
STXS
$130M
$6.38M 0.76%
1,711,912
-114,816
-6% -$542K
AHCO icon
29
AdaptHealth
AHCO
$1.49B
– –
-700,000
Closed -$17.1M
CRL icon
30
Charles River Laboratories
CRL
$10.8B
– –
-70,000
Closed -$26.4M
DVA icon
31
DaVita
DVA
$15.2B
– –
-450,000
Closed -$51.2M
LH icon
32
Labcorp
LH
$24.7B
– –
-58,200
Closed -$15.7M
TMO icon
33
Thermo Fisher Scientific
TMO
$208B
– –
-24,000
Closed -$16M
1
2

Similar funds

8KM
8 Knots Management Dallas, Texas $868M AUM 30.97% 1-Year Est. Return
MFG
MidWestOne Financial Group Iowa City, Iowa $900M AUM 23.95% 1-Year Est. Return
NP
Ninepoint Partners Toronto, Ontario, Canada $904M AUM 39.64% 1-Year Est. Return
GGI
Galaxy Group Investments New York $843M AUM 47.48% 1-Year Est. Return
WFAL
Wedbush Fund Advisers, LLC Pasadena, California $967M AUM
OBWP
O'Brien Wealth Partners Waltham, Massachusetts $756M AUM 13.93% 1-Year Est. Return
TWM
Tolleson Wealth Management Dallas, Texas $693M AUM 17.6% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return

Iron Triangle Partners's Q1 2022 Portfolio in Review

As of Q1 2022, Iron Triangle Partners held 33 positions worth $841M, up 17% from $718M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Iron Triangle Partners deployed $161M of net new capital in Q1 2022, opening 8 new positions and adding to 13 existing holdings. Its largest new stake was Illumina: 113,080 shares worth $38.4M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 99% a quarter earlier.

On the sell side, the largest reduction was Envista, an estimated $35.1M trimmed.

  • Iron Triangle Partners's largest Q1 2022 buy was Illumina: 113,080 shares worth $38.4M.
  • Iron Triangle Partners added most to Icon in Q1 2022, an estimated $39.5M increase.
  • Iron Triangle Partners's biggest Q1 2022 reduction was Envista, cutting an estimated $35.1M.
  • Iron Triangle Partners fully exited DaVita in Q1 2022, selling an estimated $51.2M.
  • Iron Triangle Partners's ten largest holdings make up 53% of its $841M portfolio in Q1 2022.
  • Iron Triangle Partners opened 8 new positions and closed 5 in Q1 2022.
  • Iron Triangle Partners's portfolio value rose 17% quarter-over-quarter to $841M.

Based on Iron Triangle Partners's 13F filing for Q1 2022, filed 16 May 2022.